Lisa Yates, PhD
About Lisa Yates, PhD
Lisa Yates, PhD, is the Director of Drug Product & Bio Drug Substance Development Procurement at Bristol Myers Squibb in New Brunswick, New Jersey. She has extensive experience in procurement, strategic sourcing, and biochemical assay development within the biopharma industry.
Company
Lisa Yates is currently employed at Bristol Myers Squibb, a renowned pharmaceutical company. She holds a leadership role at their New Brunswick, New Jersey location. Bristol Myers Squibb is a well-regarded entity in the biopharma industry, known for its innovative approaches to drug discovery and development.
Title
Lisa Yates serves as the Director of Drug Product & Bio Drug Substance Development Procurement. In this capacity, she oversees pivotal aspects of strategic sourcing and procurement, particularly focusing on Cell Therapy & Biologics Drug Substance Development.
Education and Expertise
Lisa Yates holds a PhD in Chemical Biology from Princeton University, achieved between 2011 and 2016. During this period, she also earned a Master of Arts in Chemistry. Her academic background is further supported by a BS in Chemistry and Accounting from Boston College Carroll School of Management. She has a strong foundation in biochemical assay development, mass spectrometry method development, peptide synthesis, and small molecule organic synthesis.
Background
Lisa Yates has a diverse professional background spanning multiple roles. She started as a Document Control Specialist at Kaztronix for Johnson & Johnson's Raw Materials Center before moving into academia as a PhD Candidate at Princeton University. She later joined Bristol Myers Squibb, where she advanced from Sr. Sourcing Associate to her current directorial role. She has also held positions as Procurement Category Manager and Associate Director of Novel & Emerging Technologies & Device Development Procurement.
Achievements
Throughout her career, Lisa Yates has championed continuous improvement and innovation in the biopharma industry. Her leadership in supply chain management is well-noted, alongside her hands-on expertise in quality principles. Her role has significantly impacted Bristol Myers Squibb’s strategic sourcing for Cell Therapy & Biologics Drug Substance Development.